留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肠道菌群与肾移植的研究进展

秦昊 张健 林俊

秦昊, 张健, 林俊. 肠道菌群与肾移植的研究进展[J]. 器官移植, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016
引用本文: 秦昊, 张健, 林俊. 肠道菌群与肾移植的研究进展[J]. 器官移植, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016
Qin Hao, Zhang Jian, Lin Jun. Research progress on intestinal flora and renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016
Citation: Qin Hao, Zhang Jian, Lin Jun. Research progress on intestinal flora and renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 516-520, 532. doi: 10.3969/j.issn.1674-7445.2020.04.016

肠道菌群与肾移植的研究进展

doi: 10.3969/j.issn.1674-7445.2020.04.016
基金项目: 

北京市自然科学基金面上项目 7192043

秦昊和张健为共同第一作者
详细信息
    作者简介:

    秦昊,男,1994年生,硕士研究生,研究方向为泌尿外科,Email: hot626768@126.com

    张健,男,1987年生,博士,主治医师,研究方向为泌尿外科,Email: rdfzowen@hotmail.com

    通讯作者:

    林俊,男,1973年生,博士,主任医师,研究方向为泌尿外科,Email: 13601355682@163.com

  • 中图分类号: R617, R442.2

Research progress on intestinal flora and renal transplantation

More Information
  • 摘要: 近年来,随着人们对肠道菌群的了解逐步深入,从肠道菌群角度探究肾移植术后常见并发症成为了研究热点。研究表明,肾移植受者肠道菌群的构成在手术前后存在显著差异,这种差异与肾移植术后感染、排斥反应、腹泻等诸多并发症的发生发展密切相关,并影响受者预后。本文就肠道菌群与肾移植的研究进展进行综述,以期为肾移植受者提供新的治疗思路和策略。

     

  • [1] OPAZO MC, ORTEGA-ROCHA EM, CORONADO-ARRÁZOLA I, et al. Intestinal microbiota influences non-intestinal related autoimmune diseases[J]. Front Microbiol, 2018, 9:432. DOI: 10.3389/fmicb.2018.00432.
    [2] LING Y, WATANABE Y, OKUDA S. The human gut microbiome is structured to optimize molecular interaction networks[J]. Comput Struct Biotechnol J, 2019, 17:1040-1046. DOI: 10.1016/j.csbj.2019.07.011.
    [3] CREMONESI E, GOVERNA V, GARZON JFG, et al. Gut microbiota modulate T cell trafficking into human colorectal cancer[J]. Gut, 2018, 67(11):1984-1994. DOI: 10.1136/gutjnl-2016-313498.
    [4] GRAINGER J, DAW R, WEMYSS K. Systemic instruction of cell-mediated immunity by the intestinal microbiome[J]. F1000Res, 2018, 7: F1000 Faculty Rev-1910. DOI: 10.12688/f1000research.14633.1.
    [5] HUANG SH, CHEN YH, KONG G, et al. A novel genetic island of meningitic escherichia coli K1 containing the ibeA invasion gene (GimA): functional annotation and carbon-source-regulated invasion of human brain microvascular endothelial cells[J]. Funct Integr Genomics, 2001, 1(5):312-322. doi: 10.1007/s101420100039
    [6] CHENG HY, NING MX, CHEN DK, et al. Interactions between the gut microbiota and the host innate immune response against pathogens[J]. Front Immunol, 2019, 10:607. DOI: 10.3389/fimmu.2019.00607.
    [7] 叶桂荣, 周敏捷, 于立新, 等.肾移植受者、慢性肾脏病患者和健康对照者肠道菌群的对比[J].南方医科大学学报, 2018, 38(12):1401-1408. DOI:10.12122/j.issn. 1673-4254.2018.12.01.

    YE GR, ZHOU MJ, YU LX, et al. Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects[J]. J South Med Univ, 2018, 38(12):1401-1408. DOI: 10.12122/j.issn.1673-4254.2018.12.01.
    [8] LEE JR, MUTHUKUMAR T, DADHANIA D, et al.Gut microbiota and tacrolimus dosing in kidney transplantation[J]. PLoS One, 2015, 10(3):e0122399. DOI: 10.1371/journal.pone.0122399.
    [9] KINNUNEN S, KARHAPÄÄ P, JUUTILAINEN A, et al. Secular trends in infection-related mortality after kidney transplantation[J]. Clin J Am Soc Nephrol, 2018, 13(5):755-762. DOI: 10.2215/CJN.11511017.
    [10] QI XZ, TU X, ZHA JW, et al. Immunosuppression-induced alterations in fish gut microbiota may increase the susceptibility to pathogens[J]. Fish Shellfish Immunol, 2019, 88:540-545. DOI: 10.1016/j.fsi.2019.03.035.
    [11] SWARTE JC, DOUWES RM, HU S, et al. Characteristics and dysbiosis of the gut microbiome in renal transplant recipients[J]. J Clin Med, 2020, 9(2): E386. DOI: 10.3390/jcm9020386.
    [12] CHAN S, ISBEL NM, HAWLEY CM, et al. Infectious complications following kidney transplantation-a focus on hepatitis C infection, cytomegalovirus infection and novel developments in the gut microbiota[J]. Medicina (Kaunas), 2019, 55(10): E672. DOI: 10.3390/medicina55100672.
    [13] LEI YM, CHEN L, WANG Y, et al. The composition of the microbiota modulates allograft rejection[J]. J Clin Invest, 2016, 126(7):2736-2744. DOI: 10.1172/JCI85295.
    [14] SEPULVEDA M, PIROZZOLO I, ALEGRE ML. Impact of the microbiota on solid organ transplant rejection[J]. Curr Opin Organ Transplant, 2019, 24(6):679-686. DOI: 10.1097/MOT.0000000000000702.
    [15] FRICKE WF, MADDOX C, SONG Y, et al. Human microbiota characterization in the course of renal transplantation[J]. Am J Transplant, 2014, 14(2):416-427. DOI: 10.1111/ajt.12588.
    [16] MCINTOSH CM, CHEN L, SHAIBER A, et al. Gut microbes contribute to variation in solid organ transplant outcomes in mice[J]. Microbiome, 2018, 6(1):96. DOI: 10.1186/s40168-018-0474-8.
    [17] 陈益荣, 程光, 范明齐, 等.肾移植排斥患者肠道菌群变化的研究[J].中国微生态学杂志, 2014, 26(12):1421-1424. DOI: 10.13381/j.cnki.cjm.201412016.

    CHEN YR, CHENG G, FAN MQ, et al. Changes in the intestinal flora of patients with kidney transplant rejection[J]. Chin J Microecology, 2014, 26(12):1421-1424. DOI: 10.13381/j.cnki.cjm.201412016.
    [18] ZAZA G, DALLA GASSA A, FELIS G, et al. Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: comparison between an everolimus- and a standard tacrolimus-based regimen[J]. PLoS One, 2017, 12(5):e0178228. DOI: 10. 1371/journal.pone.0178228.
    [19] FLANNIGAN KL, TAYLOR MR, PEREIRA SK, et al. An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil[J]. J Heart Lung Transplant, 2018, 37(9):1047-1059. DOI: 10.1016/j.healun.2018.05.002.
    [20] TIELEMANS MM, VAN BOEKEL GAJ, VAN GELDER T, et al. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients[J]. Transplant Rev (Orlando), 2019, 33(2):55-63. DOI: 10.1016/j.trre.2018. 11.001.
    [21] JIA J, TIAN X, JIANG J, et al. Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation[J]. Front Med, 2019, 13(4):451-460. DOI: 10.1007/s11684-018-0675-3.
    [22] ZHANG L, DONG D, JIANG C, et al. Insight into alteration of gut microbiota in clostridium difficile infection and asymptomatic C. difficile colonization[J]. Anaerobe, 2015, 34:1-7. DOI: 10.1016/j.anaerobe.2015.03.008.
    [23] GU S, CHEN Y, ZHANG X, et al. Identification of key taxa that favor intestinal colonization of clostridium difficile in an adult Chinese population[J]. Microbes Infect, 2016, 18(1):30-38. DOI: 10.1016/j.micinf.2015.09.008.
    [24] ZHAO J, NIAN L, KWOK LY, et al. Reduction in fecal microbiota diversity and short-chain fatty acid producers in methicillin-resistant staphylococcus aureus infected individuals as revealed by PacBio single molecule, real-time sequencing technology[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(8):1463-1472. DOI: 10.1007/s10096-017-2955-2.
    [25] DINLEYICI EC, MARTÍNEZ-MARTÍNEZ D, KARA A, et al. Time series analysis of the microbiota of children suffering from acute infectious diarrhea and their recovery after treatment[J]. Front Microbiol, 2018, 9:1230. DOI: 10.3389/fmicb.2018.01230.
    [26] DERY KJ, KADONO K, HIRAO H, et al. Microbiota in organ transplantation: an immunological and therapeutic conundrum?[J]. Cell Immunol, 2020, 351:104080. DOI: 10.1016/j.cellimm.2020.104080.
    [27] LOPETUSO LR, SCALDAFERRI F, PETITO V, et al. Commensal clostridia: leading players in the maintenance of gut homeostasis[J]. Gut Pathog, 2013, 5(1):23. DOI: 10.1186/1757-4749-5-23.
    [28] LEE JR, MAGRUDER M, ZHANG L, et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients[J]. Am J Transplant, 2019, 19(2):488-500. DOI: 10.1111/ajt.14974.
    [29] TAYLOR MR, FLANNIGAN KL, RAHIM H, et al. Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity[J]. Sci Adv, 2019, 5(8):eaax2358. DOI: 10.1126/sciadv.aax2358.
    [30] 王丹丹, 宋佳, 张晓岚.肠道菌群在肝脏疾病中的作用[J].临床肝胆病杂志, 2019, 35(9):2120-2123. DOI:10. 3969/j.issn.1001-5256.2019.09.053.

    WANG DD, SONG J, ZHANG XL. Research advances in the role of gut microbiota in liver diseases[J]. J ClinHepatol, 2019, 35(9):2120-2123. DOI:10.3969/j.issn.1001-5256. 2019.09.053.
    [31] KIM D, ZENG MY, NÚÑEZ G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases[J]. Exp Mol Med, 2017, 49(5):e339. DOI: 10.1038/emm.2017.24.
    [32] PANCHAL P, BUDREE S, SCHEELER A, et al. Scaling safe access to fecal microbiota transplantation: past, present, and future[J]. Curr Gastroenterol Rep, 2018, 20(4):14. DOI: 10.1007/s11894-018-0619-8.
  • 加载中
计量
  • 文章访问数:  58
  • HTML全文浏览量:  23
  • PDF下载量:  22
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-04-11
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2020-07-15

目录

    /

    返回文章
    返回